BioCentury
ARTICLE | Finance

Analyst tracks

Biotech investor, banker and analyst personnel changes

June 18, 2012 7:00 AM UTC

Jason Kolbert joined Maxim Group as SVP of biotechnology research. He was VP of business development at NeoStem Inc. (NYSE-A:NBS).

Adam Cutler departed from Credit Suisse, where he was a director and senior biotechnology analyst. He joined investor relations firm The Trout Group as a managing director...